COLOGNE, Germany: Over five days, this year’s International Dental Show (IDS), which concluded on 29 March, welcomed more than 135,000 visitors from 156 countries to
ClaroNav Inc. announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the 3rd generation of Navident (Navident 3), its dental surgery navigation system. This expands the
ClaroNav has secured quasi-equity financing from the Growth and Transition Capital team of BDC Capital, the investment arm of BDC. ClaroNav plans on using these